Poly-Iclc, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00725
Full Text
Open PDFAbstract
Available in full text
Date
April 9, 2019
Authors
Publisher
Frontiers Media SA